Core Cap Advisors, LLC Y M Abs Therapeutics, Inc. Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 46 shares of YMAB stock, worth $211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46Holding current value
$211% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
105Shares Held
27.1MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$19.5 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$14.9 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$13.5 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$10.1 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$8.95 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $201M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...